Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
Authors
Peter Popovic
Clinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Ana Kalamutova
Department of Abdominal Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
Mihajlo Djokic
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Department of Abdominal Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
Anka Cuderman
Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia
Gasper Boltezar
Diagnostic Center Bled Group, Bled, Slovenia
Blaz Trotovsek
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Department of Abdominal Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 40 - 48
Submitted on: Nov 27, 2025
Accepted on: Feb 4, 2026
Published on: Mar 24, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Peter Popovic, Ana Kalamutova, Mihajlo Djokic, Anka Cuderman, Gasper Boltezar, Blaz Trotovsek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.